Ivabradine and High Sensitivity Troponin in Type Ii Myocardial Infarction: Insights From a Randomised Controlled Study of Ivabradine in Preventing Peri-Operative Infarction, and in a Cohort of Patients With Type Ii Mi and Acute Coronary Syndromes

Funding period: 2018 - 2021

Completed

University of Melbourne Researchers